VISTAPHARM Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VISTAPHARM, and what generic and branded alternatives to VISTAPHARM drugs are available?
VISTAPHARM has twenty approved drugs.
Drugs and US Patents for VISTAPHARM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vistapharm Llc | SUCRALFATE | sucralfate | SUSPENSION;ORAL | 211884-001 | Mar 15, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Vistapharm Llc | METHADONE HYDROCHLORIDE | methadone hydrochloride | TABLET;ORAL | 040241-002 | May 29, 1998 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Vistapharm | NYSTATIN | nystatin | SUSPENSION;ORAL | 064142-001 | Jun 25, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.